According to Bio-Rad Laboratories's latest financial reports the company has $1.72 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $1.79 B | 105.17% |
2021-12-31 | $0.87 B | -12.16% |
2020-12-31 | $0.99 B | -11.03% |
2019-12-31 | $1.12 B | 31.73% |
2018-12-31 | $0.85 B | 11.81% |
2017-12-31 | $0.76 B | -9.89% |
2016-12-31 | $0.84 B | 6.77% |
2015-12-31 | $0.79 B | 13.31% |
2014-12-31 | $0.69 B | 14.57% |
2013-12-31 | $0.60 B | -33.89% |
2012-12-31 | $0.92 B | 13.28% |
2011-12-31 | $0.81 B | -20.69% |
2010-12-31 | $1.02 B | 37.64% |
2009-12-31 | $0.74 B | 205.91% |
2008-12-31 | $0.24 B | 8.82% |
2007-12-31 | $0.22 B | -54.16% |
2006-12-31 | $0.48 B | 18.16% |
2005-12-31 | $0.41 B | 14.22% |
2004-12-31 | $0.36 B | 143.29% |
2003-12-31 | $0.14 B | 435.98% |
2002-12-31 | $27.73 M | -41.16% |
2001-12-31 | $47.12 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $24.61 B | 1,324.16% | ๐บ๐ธ USA |
![]() Thermo Fisher Scientific TMO | $3.13 B | 81.28% | ๐บ๐ธ USA |
![]() Agilent Technologies A | $1.32 B | -23.10% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | $0.93 B | -46.13% | ๐บ๐ธ USA |
![]() General Electric GE | $23.65 B | 1,268.49% | ๐บ๐ธ USA |
![]() Danaher DHR | $8.57 B | 396.17% | ๐บ๐ธ USA |
![]() PerkinElmer
PKI | $2.46 B | 42.41% | ๐บ๐ธ USA |